FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2615365568> ?p ?o ?g. }

• W2615365568 endingPage "S5" @default.
• W2615365568 startingPage "S5" @default.
• W2615365568 abstract "Background: ABO-incompatible (ABOi) heart transplantation (HTx) can be performed safely in infants and results in B cell tolerance to donor ABO antigens by mechanisms that remain unclear. We showed that the inhibitory molecule CD22 is more highly expressed on splenic CD27+IgM+ B cells, which contain the vast majority of ABO-specific antibody secreting cell precursors, compared to other splenic B cell subsets. CD22 expression was highest on infant CD27+IgM+ B cells and decreased with age. Binding of CD22 to sialic acids (CD22L) on the same cell (cis-binding) or different cells (trans-binding) regulates B cell activation and may lead to B cell tolerance. Here, we studied whether CD22-CD22L cis-binding affects activation of CD27+IgM+ and CD27-IgM+ B cells from pediatric and adult spleen. Methods: CD27+IgM+ and CD27-IgM+ B cells were isolated via fluorescence-activated cell sorting from pediatric (n=3; age range: 0–2.5 yr) and adult (n=3; age range: 21–46 yr) spleen obtained from organ donors. To ‘break’ CD22-CD22L cis-binding, sorted B cells were treated with neuraminidase (NEU) to cleave surface sialic acids. Activation of B cells was defined by analyzing intracellular phosphorylation of PLCγ2 (pY759) after stimulation with anti-IgM antibodies using ‘phospho-flow’ cytometry. Results: Kinetics of pY759 signaling after stimulation were similar between untreated CD27+IgM+ and CD27-IgM+ B cells as well as pediatric and adult samples. At peak response (1–3 min after stimulation), the median fluorescence intensity (MFI) of pY759 in pediatric CD27+IgM+ B cells was comparable to that in pediatric CD27-IgM+ B cells (350–614 vs. 259–565), whereas in adult cells the MFI was higher in CD27+IgM+ B cells than in CD27-IgM+ B cells (540–912 vs. 248–328). NEU treatment had a strong effect on kinetics and magnitude of pY759 signaling in both pediatric and adult CD27+IgM+ B cells: the MFI of pY759 increased to 506–2023 and 1086–2051, respectively, at peak response (4–8 min after stimulation). In contrast, treatment had minimal effect on pY759 signaling in CD27-IgM+ B cells. Conclusion: NEU treatment increased the magnitude of pY759 signaling in stimulated CD27+IgM+ B cells, but not CD27-IgM+ B cells, suggesting that CD22-CD22L cis-binding may play a role in control of activation of CD27+IgM+ B cells. This finding may contribute to unraveling mechanisms of B cell tolerance in ABOi HTx in children. Canadian National Transplant Research Program (CNTRP) investigator." @default.
• W2615365568 created "2017-05-26" @default.
• W2615365568 creator A5005246771 @default.
• W2615365568 creator A5011343989 @default.
• W2615365568 creator A5016614279 @default.
• W2615365568 creator A5038480610 @default.
• W2615365568 creator A5045177597 @default.
• W2615365568 creator A5065498227 @default.
• W2615365568 date "2017-05-01" @default.
• W2615365568 modified "2023-09-25" @default.
• W2615365568 title "Regulation of Human CD27+IgM+ B Cell Activation by Cis-Binding of the Inhibitory Molecule CD22 to CD22 Ligand (CD22L)" @default.
• W2615365568 doi "https://doi.org/10.1097/01.tp.0000520297.36145.fc" @default.
• W2615365568 hasPublicationYear "2017" @default.
• W2615365568 type Work @default.
• W2615365568 sameAs 2615365568 @default.
• W2615365568 citedByCount "1" @default.
• W2615365568 countsByYear W26153655682022 @default.
• W2615365568 crossrefType "journal-article" @default.
• W2615365568 hasAuthorship W2615365568A5005246771 @default.
• W2615365568 hasAuthorship W2615365568A5011343989 @default.
• W2615365568 hasAuthorship W2615365568A5016614279 @default.
• W2615365568 hasAuthorship W2615365568A5038480610 @default.
• W2615365568 hasAuthorship W2615365568A5045177597 @default.
• W2615365568 hasAuthorship W2615365568A5065498227 @default.
• W2615365568 hasConcept C111700020 @default.
• W2615365568 hasConcept C153911025 @default.
• W2615365568 hasConcept C159654299 @default.
• W2615365568 hasConcept C176080213 @default.
• W2615365568 hasConcept C185592680 @default.
• W2615365568 hasConcept C203014093 @default.
• W2615365568 hasConcept C2778453870 @default.
• W2615365568 hasConcept C86803240 @default.
• W2615365568 hasConceptScore W2615365568C111700020 @default.
• W2615365568 hasConceptScore W2615365568C153911025 @default.
• W2615365568 hasConceptScore W2615365568C159654299 @default.
• W2615365568 hasConceptScore W2615365568C176080213 @default.
• W2615365568 hasConceptScore W2615365568C185592680 @default.
• W2615365568 hasConceptScore W2615365568C203014093 @default.
• W2615365568 hasConceptScore W2615365568C2778453870 @default.
• W2615365568 hasConceptScore W2615365568C86803240 @default.
• W2615365568 hasIssue "5S-3" @default.
• W2615365568 hasLocation W26153655681 @default.
• W2615365568 hasOpenAccess W2615365568 @default.
• W2615365568 hasPrimaryLocation W26153655681 @default.
• W2615365568 hasRelatedWork W1524827063 @default.
• W2615365568 hasRelatedWork W1977987728 @default.
• W2615365568 hasRelatedWork W2043544147 @default.
• W2615365568 hasRelatedWork W205114876 @default.
• W2615365568 hasRelatedWork W2154750665 @default.
• W2615365568 hasRelatedWork W2314668519 @default.
• W2615365568 hasRelatedWork W2582689618 @default.
• W2615365568 hasRelatedWork W2914913137 @default.
• W2615365568 hasRelatedWork W2969961587 @default.
• W2615365568 hasRelatedWork W3184498267 @default.
• W2615365568 hasVolume "101" @default.
• W2615365568 isParatext "false" @default.
• W2615365568 isRetracted "false" @default.
• W2615365568 magId "2615365568" @default.
• W2615365568 workType "article" @default.